Approximately $78 Billion is handled by the Alaska Permanent Fund and they have put a lot more money into certain types of businesses.
They’ve tripled how much of the company Walmart they own, now owning about 31,500 shares. This happened because prices for things people buy are going up in the United States, especially for groceries.
Walmart’s value on the stock market went up by 15% in the first part of the year, which is better than the prevailing market’s 10% increase.
This is because Walmart has been making a lot of money and buying other companies, like Vizio, which makes smart TVs.
The Alaska Permanent Fund decided to put more money into Walmart, as well as investing more in Kroger and Ford.
They’re doing this because they want to deal with the rising prices and make money from businesses that are doing well and have the potential to grow.
Competitive Shifts Faced by The Grocery Sector
Changes are happening in the grocery business. Kroger wants to get bigger by buying Albertsons, but the government might not allow it because it could make things less competitive.
Kroger is feeling the heat from big companies like Walmart, Amazon, and Costco.
The Alaska Permanent Fund is putting more money into Kroger, showing they think the grocery business will keep growing, even though there are challenges and rules from the government.
Walmart sells way more groceries than Kroger, showing how competitive things are.
What Are The Other Targets Of Alaska Fubds?
Apart from groceries, the Alaska Permanent Fund is also interested in cars and medicine. They’ve bought more shares in Ford, owning 203,300 now, up from before.
Ford’s value went up by 9% at the beginning of the year, but it dropped by 5% later on, and they had some delays with their electric cars. On the other hand, Pfizer, a company that makes medicine, didn’t do as well.
Their value dropped by 3.6% at the start of the year and then by 7% since March. The fund decided to sell some of their Pfizer shares, now owning 16,700, down from before.
This might mean they’re worried about how well the medicine business will do soon, even though there could be money to make from new vaccines and selling parts of the business.
